References
Nakaya Y et al. (2002) Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture.[comment]. J Gastroenterol 37: 531–536
Watanabe A et al. (1983) Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis. Acta Med Okayama 37: 321–333
Plauth M et al. (1993) Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol 17: 308–314
Marchesini G et al. (1990) Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 11: 92–101
Egberts EH et al. (1985) Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology 88: 887–895
Marchesini G et al. (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.[see comment]. Gastroenterology 124: 1792–1801
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Charlton, M. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?. Nat Rev Gastroenterol Hepatol 3, 72–73 (2006). https://doi.org/10.1038/ncpgasthep0392
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0392
- Springer Nature Limited